Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × pazopanib × 30 days × Clear all

Sponsor

Conditions

Sarcoma 3 Carcinoma, Renal Cell 3 Solid Neoplasm 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Perivascular Epithelioid Cell Neoplasms 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Nerve Sheath Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Granuloma, Plasma Cell 1 Fibrosarcoma 1 Dermatofibrosarcoma 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Extraskeletal Myxoid 1

Interventions

pembrolizumab 2 durvalumab 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1 cemiplimab 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡